| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Bhattacharyya, Sanjeev |
| dc.contributor.author | Botezatu, Simona |
| dc.contributor.author | Mandoli, Giulia Elena |
| dc.contributor.author | Vinco, Giulia |
| dc.contributor.author | Biering-Sørensen, Tor |
| dc.contributor.author | Manka, Robert |
| dc.contributor.author | Rodríguez Palomares, José F |
| dc.date.accessioned | 2025-10-29T08:24:08Z |
| dc.date.available | 2025-10-29T08:24:08Z |
| dc.date.issued | 2025-01 |
| dc.identifier.citation | Bhattacharyya S, Botezatu SB, Mandoli GE, Vinco G, Biering-Sørensen T, Manka R, et al. EACVI survey on evaluation and quantification of aortic regurgitation by multi-modality imaging. Eur Hear J - Imaging Methods Pract. 2025 Jan;3(1):qyaf058. |
| dc.identifier.issn | 2755-9637 |
| dc.identifier.uri | http://hdl.handle.net/11351/13948 |
| dc.description | Aortic regurgitation; Cardiac magnetic resonance; Left ventricle |
| dc.description.abstract | Aims: To investigate the real-world, current clinical practice of the assessment and management of aortic regurgitation (AR).
Methods and results: An electronic survey was distributed to cardiovascular imaging specialists by the European Society Association of Cardiovascular Imaging Scientific Initiatives Committee. Three hundred respondents from 66 countries completed the survey. In patients where initial qualitative evaluation suggested moderate AR, regurgitation severity was further characterized using vena contracta in 83%, pressure half-time in 70%, jet width/outflow tract diameter in 59%, regurgitant volume/effective orifice area 57% and three-dimensional vena contract in 20% of respondents. Cardiac magnetic resonance (CMR) was used by 72% of respondents when transthoracic echocardiographic (TTE) image quality was poor and 74% of respondents when there was discordance between Doppler findings and ventricular assessments. CMR 4-dimensional flow was performed by 19% of respondents. Left ventricular (LV) diameters were measured at the mitral valve level by 52% and at the mid LV by 43% of respondents. LV volumes were measured using TTE by 70%, with CMR by 40% and with CT by 2% of respondents.
Conclusion: There is heterogeneity in the echocardiographic methods used to quantify AR. The vena-contracta is the most commonly used for assessment of AR severity with relative underutilisation of quantitative methods. CMR is widely used to assess AR severity when echocardiographic assessments are uncertain. There is variation in the anatomical location to measure LV dilatation and variable use of LV volumes which may impact decision making for intervention. |
| dc.language.iso | eng |
| dc.publisher | Oxford University Press |
| dc.relation.ispartofseries | European Heart Journal - Imaging Methods and Practice;3(1) |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.source | Scientia |
| dc.subject | Ecocardiografia |
| dc.subject | Enquestes |
| dc.subject | Insuficiència aòrtica - Imatgeria |
| dc.subject.mesh | Echocardiography |
| dc.subject.mesh | Aortic Valve Insufficiency |
| dc.subject.mesh | /diagnostic imaging |
| dc.subject.mesh | Surveys and Questionnaires |
| dc.title | EACVI survey on evaluation and quantification of aortic regurgitation by multi-modality imaging |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1093/ehjimp/qyaf058 |
| dc.subject.decs | ecocardiografía |
| dc.subject.decs | insuficiencia de la válvula aórtica |
| dc.subject.decs | /diagnóstico por imagen |
| dc.subject.decs | encuestas y cuestionarios |
| dc.relation.publishversion | https://doi.org/10.1093/ehjimp/qyaf058 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Bhattacharyya S] Echocardiography Laboratory, St Bartholomew’s Hospital, London, UK. Cleveland Clinic London, London, UK. William Harvey Research Institute, Queen Mary University of London, London, UK. [Botezatu SB] Department of Cardiology, University of Medicine and Pharmacy ‘Carol Davila’, Euroecolab, Bucharest, Romania. [Mandoli GE] Division of Cardiology, Department of Medical Biotechnologies, University of Siena, Siena, Italy. [Vinco G] Department of Cardiology, Verona Integrated University Hospital, Verona, Italy. [Biering-Sørensen T] Department of Biomedical Sciences, Faculty of Health and Medical Sciences, Center for Translational Cardiology and Pragmatic Randomized Trials, University of Copenhagen, Copenhagen, Denmark. Department of Cardiology, Cardiovascular Non-Invasive Imaging Research Laboratory, Copenhagen University Hospital—Herlev and Gentofte, Copenhagen, Denmark. Steno Diabetes Center, Copenhagen, Denmark. Department of Cardiology, Copenhagen University Hospital—Rigshospitalet, Copenhagen, Denmark. [Manka R] Department of Cardiology, University Heart Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Institute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland. [Rodriguez-Palomares J] Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
| dc.identifier.pmid | 40584918 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |